07/01/2020 - 21:41

MGC unveils new “Mercury Pharma” medicinal cannabis brand

07/01/2020 - 21:41

Bookmark

Save articles for future reference.

Medicinal cannabis player, MGC Pharmaceuticals, has unveiled a new medicinal cannabis-based line for Australian and New Zealand markets to be called “Mercury Pharma” with its first product, Mercury Pharma 100, a prescription-only 100mg/mL cannabidiol product. The company has received purchase orders for over 2,000 product units already, which will see revenues of around $270,000 realised.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options